Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01084096Not ApplicableCompleted

Trial of the Use of Antenatal Corticosteroids in Developing Countries

Role: collaborator

NCT03700749Phase 3Unknown

FALCON Trial Testing Measures to Reduce Surgical Site Infection

Role: collaborator

NCT02208609Not ApplicableCompleted

Zinc Bioavailability From Amaranth-enriched Maize Tortillas

Role: collaborator

NCT02263118Not ApplicableCompleted

A Mobile-health Pilot Experiment Targeting Mothers With Newborns in Rural Areas of San Juan Sacatepequez, Guatemala

Role: lead

All 4 trials loaded